Intabio acquisition expands SCIEX portfolio of impactful solutions to accelerate biotherapeutic development

Due to the nature of their production, biotherapeutics are difficult to manufacture. Growth conditions, purification protocols and formulation requirements can introduce unintended modifications into the protein structure that may affect its efficacy and safety. Imaged capillary isoelectric focusing (iCIEF) provides a critical measure of quality throughout the development and manufacturing of biotherapeutics by offering rapid, robust and high-resolution charge variant analysis.